Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ROCKVILLE, Md., Sept. 22, 2005 (PRIMEZONE) -- Cytomedix, Inc. ("Cytomedix" or the "Company") (AMEX:GTF) has launched a comprehensive audit of its prospective, randomized, double-blinded, controlled...
-
ROCKVILLE, Md., Sept. 13, 2005 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF) Chief Executive Officer and Chairman Kshitij Mohan, Ph. D., today issued the following statement concerning the preliminary...
-
ROCKVILLE, Md., Sept. 12, 2005 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF) today announced that preliminary analysis of a clinical trial for its AutoloGel(tm) platelet gel therapy system for the...
-
ROCKVILLE, Md., Sept. 6, 2005 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has appointed The Wall Street Group, Inc., as its financial public relations advisor. The Wall Street...
-
ROCKVILLE, Md., Aug. 10, 2005 (PRIMEZONE) -- Cytomedix (AMEX:GTF) today announced it has completed the treatment phase of the company's clinical trial involving 72 patients at 14 sites designed to...
-
ROCKVILLE, Md., July 15, 2005 (PRIMEZONE) -- Cytomedix (AMEX:GTF) today announced the appointment of Andrew Maslan to the position of chief financial officer, succeeding Bill Allender. Maslan, 35,...
-
ROCKVILLE, Md., June 27, 2005 (PRIMEZONE) -- Cytomedix (AMEX:GTF) today announced that Perfusion Partners and Associates Inc. (PPAI), based in Fort Meyers, Florida, and its affiliate organization,...
-
ROCKVILLE, Md., June 21, 2005 (PRIMEZONE) -- Cytomedix (AMEX:GTF) today announced that Dr. Kshitij Mohan, chief executive officer, will assume the additional position of chairman of the board...
-
ROCKVILLE, Md., June 16, 2005 (PRIMEZONE) -- Cytomedix (AMEX:GTF) today announced the appointment of Andrew Maslan to the new position of corporate controller, effective, July 1, 2005. Maslan, 35,...
-
ROCKVILLE, MD, May 26, 2005 (PRIMEZONE) -- Cytomedix, Inc. (OTCBB:CYME) today announced that its listing application for the American Stock Exchange has been approved. The company's common stock is...